(4), using GnRH agonists and hCG together successfully suppressed the “Flare-up” effect of GnRH agonists, quickly suppress the female gonadal axis, which reduced the risk of OHSS, and increased the success rate of assisted reproductive technology. This evidence concerns the gene GNRH1 and ovarian hyperstimulation syndrome.